First trial of a new hepatitis C vaccine shows promise
1 April 2014
A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University reports. Professor Paul Klenerman is one of the lead researchers on this study.